Discovery of zoniporide: A potent and selective sodium–hydrogen exchanger type 1 (NHE-1) inhibitor with high aqueous solubility

Angel Guzmán-Pérez(Pfizer (United States)), Ronald T. Wester(Pfizer (United States)), Mary C. Allen(Pfizer (United States)), Janice A. Brown(Pfizer (United States)), Allan R. Buchholz(Pfizer (United States)), Ewell R. Cook(Pfizer (United States)), Wesley Day(Pfizer (United States)), E.S. Hamanaka(Pfizer (United States)), Scott P. Kennedy(Pfizer (United States)), Delvin R. Knight(Pfizer (United States)), Paul Kowalczyk(Pfizer (United States)), Ravi B. Marala(Pfizer (United States)), Christian J. Mularski(Pfizer (United States)), William A. Novomisle(Pfizer (United States)), Roger B. Ruggeri(Pfizer (United States)), W. Ross Tracey(Pfizer (United States)), Roger J. Hill(Pfizer (United States))
Bioorganic & Medicinal Chemistry Letters
March 1, 2001
10.1016/s0960-894x(01)00059-2
Cited by 78Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis